Search

everythinglearnresearchcommunity

for

Search:↓

The research concluded that selection significantly shaped the genetic variation of the X chromosome, with certain regions affected by past selective events.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Certain drugs change freshwater snail shells to a "banana" shape.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Use antiandrogens and other treatments for hair loss.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Spironolactone helps regrow hair in women with hair loss.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

The normal human prostate does not significantly affect blood DHT levels.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Testosterone helps human pancreatic cells increase insulin release.